- Home
- Publications
- Publication Search
- Publication Details
Title
Transcription Factors in Cancer Development and Therapy
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2296
Publisher
MDPI AG
Online
2020-08-17
DOI
10.3390/cancers12082296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcription Factor Inhibition: Lessons Learned and Emerging Targets
- (2020) Andrew Chen et al. TRENDS IN MOLECULAR MEDICINE
- ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy
- (2020) Jiao Meng et al. Cell Death & Disease
- Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance
- (2020) Mingjun Bi et al. NATURE CELL BIOLOGY
- Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
- (2020) Namrata Bora-Singhal et al. Scientific Reports
- c‑Myc maintains the self‑renewal and chemoresistance properties of colon cancer stem cells
- (2019) Huan‑Le Zhang et al. Oncology Letters
- The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
- (2019) A. C. Hepburn et al. ONCOGENE
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors
- (2019) Irem Yalim-Camci et al. MOLECULAR CARCINOGENESIS
- Nuclear receptors: recent drug discovery for cancer therapies
- (2019) Linjie Zhao et al. ENDOCRINE REVIEWS
- Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
- (2019) Linlin Lu et al. CELL DEATH AND DIFFERENTIATION
- ETS transcription factors as emerging drug targets in cancer
- (2019) Michael Hsing et al. MEDICINAL RESEARCH REVIEWS
- Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma
- (2019) Ling Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells
- (2019) Dongjing Yan et al. ONCOLOGY REPORTS
- Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma
- (2019) Christian Gluck et al. PLoS Genetics
- Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
- (2019) Xiaohong Ruan et al. Molecular Therapy-Oncolytics
- DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- (2019) Ssu-Chuan Lai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Darolutamide For Castration-Resistant Prostate Cancer
- (2019) Diogo A Bastos et al. OncoTargets and Therapy
- The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
- (2019) Fan Liang et al. Oncogenesis
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
- (2019) Braicu et al. Cancers
- Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist
- (2018) Earl Clarke et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SOX2-mediated upregulation of CD24 promotes adaptive resistance towards targeted therapy in melanoma
- (2018) Laura Hüser et al. INTERNATIONAL JOURNAL OF CANCER
- Recent Advances in Prostate Cancer Treatment and Drug Discovery
- (2018) Ekaterina Nevedomskaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
- (2018) Dennis J. Slamon et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Transcription Factors for Cancer Treatment
- (2018) Mélanie Lambert et al. MOLECULES
- MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state
- (2018) Vittoria Poli et al. Nature Communications
- AP-1 confers resistance to anti-cancer therapy by activating XIAP
- (2018) Yuan Wang et al. Oncotarget
- E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
- (2018) Wenjun Lan et al. Scientific Reports
- Double agents: genes with both oncogenic and tumor-suppressor functions
- (2018) Libing Shen et al. Oncogenesis
- Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics
- (2018) Liam J. Hawkins et al. PeerJ
- Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
- (2018) Harshul Pandit et al. BMC CANCER
- WNT5A as a therapeutic target in breast cancer
- (2018) Chandra Prakash Prasad et al. CANCER AND METASTASIS REVIEWS
- Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)
- (2018) Yosup Rew et al. JOURNAL OF MEDICINAL CHEMISTRY
- ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR
- (2018) Zhiyi Shao et al. PHARMACOLOGICAL RESEARCH
- A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumour Activity of Sorafenib in Hepatocelluar Carcinoma In Vitro and In Vivo
- (2018) Kai Zhang et al. Molecular Therapy-Nucleic Acids
- Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells
- (2018) Alessandro Furlan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
- (2018) Yuanyuan Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
- (2018) Yen-Dun Tony Tzeng et al. Frontiers in Pharmacology
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC
- (2017) Mingchen Ba et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
- (2017) Jolieke G. van Oosterwijk et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
- (2017) Hazel J. Hunt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer
- (2017) Rui Xiong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
- (2017) Eleonora Molinaro et al. Nature Reviews Endocrinology
- Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis
- (2017) Vineet K. Dhiman et al. NATURE REVIEWS GENETICS
- Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
- (2017) Shuping Yin et al. PLoS One
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma
- (2017) Xueju Wang et al. Oncotarget
- Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma
- (2017) Xiqing Li et al. Oncotarget
- Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cells
- (2017) Shojiro Kitajima et al. Oncotarget
- Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors
- (2017) John E. Bisi et al. Oncotarget
- The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
- (2017) Min Yu et al. Oncotarget
- WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
- (2017) Marcus M. Fischer et al. Science Advances
- NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo
- (2017) Xiaolu Cui et al. Scientific Reports
- TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer
- (2017) Xiaoting Jia et al. Scientific Reports
- Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
- (2016) Lisi Qi et al. CURRENT DRUG METABOLISM
- Pushing estrogen receptor around in breast cancer
- (2016) Elgene Lim et al. ENDOCRINE-RELATED CANCER
- Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies
- (2016) Conleth G Murphy et al. ENDOCRINE-RELATED CANCER
- AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression.
- (2016) Yichun Qiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance
- (2016) Salvador Alonso et al. JOURNAL OF CLINICAL INVESTIGATION
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
- (2016) F Fan et al. LEUKEMIA
- BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
- (2016) Daniel Dauch et al. NATURE MEDICINE
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
- (2016) Xiaoyong Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
- (2016) Chia-Sing Lu et al. Oncotarget
- Epigenetics in Cancer: A Hematological Perspective
- (2016) Maximilian Stahl et al. PLoS Genetics
- Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression
- (2016) Terumasa Sowa et al. Cancer Medicine
- Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women
- (2016) Nicoletta Provinciali et al. Expert Review of Clinical Pharmacology
- Hypoxia and metabolic adaptation of cancer cells
- (2016) K L Eales et al. Oncogenesis
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Human Prostate Cancer Hallmarks Map
- (2016) Dipamoy Datta et al. Scientific Reports
- Nail improvement during alitretinoin treatment: three case reports and review of the literature
- (2015) N. Milanesi et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader
- (2015) Suzanne E Wardell et al. ENDOCRINE-RELATED CANCER
- Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma
- (2015) Erica M. Stringer-Reasor et al. GYNECOLOGIC ONCOLOGY
- AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
- (2015) S. M. Guichard et al. MOLECULAR CANCER THERAPEUTICS
- Progesterone receptor modulates ERα action in breast cancer
- (2015) Hisham Mohammed et al. NATURE
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation
- (2015) Y Liu et al. ONCOGENE
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
- (2015) Nora Sundahl et al. PHARMACOLOGY & THERAPEUTICS
- Progesterone receptor-estrogen receptor crosstalk: a novel insight
- (2015) Christoforos Thomas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Discovery of Compound A – a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity
- (2015) Ekaterina Lesovaya et al. Oncotarget
- Vorinostat-An overview
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF DERMATOLOGY
- The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy
- (2014) Andres J. Orqueda et al. BIOCHEMICAL PHARMACOLOGY
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
- (2014) Jinrong Wei et al. Cancer Cell International
- Nuclear Receptors, RXR, and the Big Bang
- (2014) Ronald M. Evans et al. CELL
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- Enobosarm (GTx-024, S-22): a potential treatment for cachexia
- (2014) Reshmi Srinath et al. Future Oncology
- The potential role of HIF on tumour progression and dissemination
- (2014) Sandeep Unwith et al. INTERNATIONAL JOURNAL OF CANCER
- Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia: Results From a Randomized Controlled Trial
- (2014) Katsuji Shinagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells
- (2014) Azriel Schmidt et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2
- (2014) Chun-Xiong Zhao et al. MEDICAL ONCOLOGY
- The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis
- (2014) Jianzhong Chen et al. MEDICINAL RESEARCH REVIEWS
- Evolution of androgen receptor targeted therapy for advanced prostate cancer
- (2014) Yien Ning Sophia Wong et al. Nature Reviews Clinical Oncology
- Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors
- (2014) Robin E. Norris et al. PEDIATRIC BLOOD & CANCER
- Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
- (2014) Xiao-Na Pan et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss
- (2014) Barry S. Komm et al. STEROIDS
- NF-κB Functions in Tumor Initiation by Suppressing the Surveillance of Both Innate and Adaptive Immune Cells
- (2014) David J. Wang et al. Cell Reports
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells
- (2013) Zhiqiang Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma
- (2013) Yue Cheng et al. BMC CELL BIOLOGY
- Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells
- (2013) Yuhua Lu et al. CANCER LETTERS
- Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
- (2013) X. H.- F. Zhang et al. CLINICAL CANCER RESEARCH
- RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
- (2013) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer
- (2013) Meghan L Verschoor et al. Molecular Cancer
- NF-κB is a critical mediator of BRCA1-induced chemoresistance
- (2013) M T Harte et al. ONCOGENE
- Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
- (2012) Hu Wang et al. Anti-Cancer Agents in Medicinal Chemistry
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Mitotic and mitogenic Wnt signalling
- (2012) Christof Niehrs et al. EMBO JOURNAL
- Molecular and cellular processes underlying the hallmarks of head and neck cancer
- (2012) Jonathan M. Bernstein et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Action of RORs and their ligands in (patho)physiology
- (2012) Laura A. Solt et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Functional Mechanisms for Human Tumor Suppressors
- (2012) Wanpeng Sun et al. Journal of Cancer
- Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
- (2011) Puja Sapra et al. ANGIOGENESIS
- ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
- (2011) Taku Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
- (2011) Jordi Rodon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers
- (2011) R. L. Keith et al. Cancer Prevention Research
- STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
- (2011) R. B. Corcoran et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor -Initiated Prostate Cancer Epithelial-Mesenchymal Transition
- (2011) Y.-N. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance
- (2011) Tobias Sinnberg et al. PLoS One
- The Anticancer Plant Triterpenoid, Avicin D, Regulates Glucocorticoid Receptor Signaling: Implications for Cellular Metabolism
- (2011) Valsala Haridas et al. PLoS One
- -catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness
- (2011) E. Sanchez-Tillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of p53 in Cell Death and Human Cancers
- (2011) Toshinori Ozaki et al. Cancers
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis
- (2010) R. Wiehle et al. Cancer Prevention Research
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
- (2010) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Krüppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression
- (2010) Jennifer L. Yori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- Ets-1 Regulates Energy Metabolism in Cancer Cells
- (2010) Meghan L. Verschoor et al. PLoS One
- Retinoid X receptors: common heterodimerization partners with distinct functions
- (2010) Philippe Lefebvre et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The expression and significance of HIF-1α and GLUT-3 in glioma
- (2009) Yang Liu et al. BRAIN RESEARCH
- E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
- (2009) Otto Schmalhofer et al. CANCER AND METASTASIS REVIEWS
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis
- (2009) L. Qin et al. CANCER RESEARCH
- Helicobacter pylori Cytotoxin-Associated Gene A Activates the Signal Transducer and Activator of Transcription 3 Pathway In vitro and In vivo
- (2009) D. M. Bronte-Tinkew et al. CANCER RESEARCH
- FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
- (2009) Victoria Moreno-Manzano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SKIP Interacts with c-Myc and Menin to Promote HIV-1 Tat Transactivation
- (2009) Vanessa Brès et al. MOLECULAR CELL
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Epstein–Barr virus-derived EBNA2 regulates STAT3 activation
- (2008) Ryuta Muromoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Alitretinoin: a comprehensive review
- (2008) Caleb Cheng et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Selective progesterone receptor modulators 3: use in oncology, endocrinology and psychiatry
- (2008) Giuseppe Benagiano et al. EXPERT OPINION ON PHARMACOTHERAPY
- E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas
- (2008) T De Meyer et al. JOURNAL OF PATHOLOGY
- The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression
- (2008) L. Qin et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Retinoic acid in development: towards an integrated view
- (2008) Karen Niederreither et al. NATURE REVIEWS GENETICS
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
- (2008) Yu-Chih Chen et al. PLoS One
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
- (2008) Bikul Das et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now